• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

AACE: Type 2 Diabetes Complications Exact Heavy Tolls


SEATTLE -- Nearly a third of Americans with type 2 diabetes have chronic kidney disease, and about 20% have diabetic eye disease and foot problems, a surveillance report shows.

SEATTLE, April 13 -- Nearly a third of the estimated 18 million Americans with type 2 diabetes have from chronic kidney disease, and about 20% have diabetic eye disease and foot problems, a surveillance report shows.

Microvascular and macrovascular complications from type 2 diabetes account for nearly billion in direct medical costs, according to the report, titled State of Diabetes Complications in America, released by the American Association of Clinical Endocrinologists at its 2007 meeting here.

"On the national level, an estimated three out of five people with diabetes (57.9%) have one or more of the complications associated with diabetes," the report states. "These health problems are taking a heavy toll on the U.S. financially."

The report was developed by the AACE in partnership with the Amputee Coalition of America, the cardiac support group Mended Hearts, the National Federation of the Blind, and the National Kidney Foundation.

It melded data from the CDC's National Health and Nutrition Examination Survey (NHANES) with medical expenditure information from the Agency for Health Care Research and Quality and the National Center for Health Statistics.

The purpose of the study was "to call attention to the issue of diabetes-related complications and bring about change in the way type 2 diabetes is managed in the U.S."

Among the report's key findings:

  • Estimated annual health care costs for a person with type 2 diabetes and related complications are ,000, about ,600 of which is out-of-pocket.
  • Macrovascular complications of diabetes include myocardial infarction in 9.8%, angina/chest pain in 9.5% coronary heart disease in 9.1%, congestive heart failure in 7.9%, and stroke in 6.6%.
  • Chronic kidney disease, the most prevalent complication of type 2 diabetes, affects an estimated 27.8% of those with the disease, compared with only 6.1% of those with normal glycemia. Diabetic foot problems affect 22.9%, and diabetic eye disease affects 18.9% of people with type 2 diabetes.
  • In every category of microvascular and macrovascular complications, the estimated prevalence is higher among men then among women. For example, 30.4% of men with hyperglycemia have chronic kidney disease, compared with 25% of hyperglycemic women, and diabetic eye disease occurs in 20.3% of diabetic men, compared with 17.5% of diabetic women.
  • The prevalence of most but not all complications is higher among non Hispanic blacks and Hispanics than non-Hispanic whites. For example, 24.5% of whites with diabetes have chronic kidney disease, compared with 35.2% of blacks, and 37.6% of Hispanics/Mexican Americans.
  • Myocardial infarction is the costliest diabetes-associated complication, at ,519 per case. Chronic kidney disease costs ,002 per patient, followed closely by heart failure at ,932 and stroke at ,806 annually. Coronary heart disease drains ,062 annually from health-care coffers, and diabetic eye disease accounts for ,785.

Related Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.